tiprankstipranks
N4 Pharma PLC (GB:THAT)
LSE:THAT
UK Market
Want to see GB:THAT full AI Analyst Report?

N4 Pharma (THAT) Financial Statements

7 Followers

N4 Pharma Financial Overview

N4 Pharma's market cap is currently £14.18M. The company's EPS TTM is p-0.0017; its P/E ratio is -3.24; N4 Pharma is scheduled to report earnings on June 23, 2026, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 7.26K£ 7.28K£ 1.95K£ 0.00£ 0.00
Gross Profit£ 0.00£ 7.28K£ 1.95K£ 0.00£ 0.00
Operating Income£ -1.10M£ -1.22M£ -1.43M£ -1.19M£ -1.84M
EBITDA£ -1.10M£ -1.22M£ -1.33M£ -1.19M£ -1.84M
Net Income£ -1.21M£ -1.06M£ -1.27M£ -1.03M£ -1.54M
Balance Sheet
Cash & Short-Term Investments£ 1.08M£ 625.97K£ 1.03M£ 1.92M£ 1.78M
Total Assets£ 1.17M£ 775.77K£ 1.28M£ 2.17M£ 2.34M
Total Debt£ 0.00£ 0.00£ 0.00£ 0.00£ 0.00
Net Debt£ -1.08M£ -625.97K£ -1.03M£ -1.92M£ -1.78M
Total Liabilities£ 97.96K£ 124.37K£ 81.73K£ 77.89K£ 212.73K
Stockholders' Equity£ 1.07M£ 647.65K£ 1.13M£ 2.09M£ 2.13M
Cash Flow
Free Cash Flow£ -1.16M£ -971.50K£ -1.21M£ -828.26K£ -1.77M
Operating Cash Flow£ -1.16M£ -971.50K£ -1.21M£ -828.26K£ -1.77M
Investing Cash Flow£ 0.00£ 0.00£ 781.00£ 0.00£ 0.00
Financing Cash Flow£ 1.61M£ 570.36K£ 315.90K£ 963.77K£ 677.00
Currency in GBP

N4 Pharma Earnings and Revenue History

N4 Pharma Debt to Assets

N4 Pharma Cash Flow

N4 Pharma Forecast EPS vs Actual EPS